Caption Management »

Outlook Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $768k 144k 5.34

More positions owned by Caption Management

Citigroup Com New Call Option (C)
Capri Holdings SHS Call Option (CPRI)
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Verizon Communications Put Option (VZ)
Albertsons Cos Common Stock Call Option (ACI)
United States Steel Corporation Call Option (X)
Frontier Communications Pare Call Option (FYBR)
Celestica Call Option (CLS)
AmerisourceBergen Call Option (COR)
Alphabet Cap Stk Cl C Put Option (GOOG)
Verisign Call Option (VRSN)
Vistra Energy Call Option (VST)
Tapestry Call Option (TPR)
Arcellx Common Stock Call Option (ACLX)
Royal Caribbean Cruises Call Option (RCL)

View all positions for Caption Management

Top funds holding Outlook Therapeutics

Tang Capital Management
Dr. Jeffrey R. Jay, M.D.
BlackRock
BlackRock
Sphera Funds Management
Vanguard Group
Altium Capital Management
Geode Capital Management
Caligan Partners
Schonfeld Strategic Advisors
State Street Corporation
Woodline Partners
Caption Management
Northern Trust
Federated Investors

View all funds holding Outlook Therapeutics